Vienna, Austria

Sabine Goller


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sabine Goller: Innovator in Gene Therapy

Introduction

Sabine Goller is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of gene therapy, particularly through her innovative work involving retroviral vectors. Her research focuses on targeted integration into chromosomes, which has important implications for treating genetic defects and viral infections.

Latest Patents

Sabine Goller holds a patent for her invention titled "Targeted integration into chromosomes using retroviral vectors." This patent relates to a retroviral vector encoding heterologous genes, which is particularly useful for gene therapy applications. The invention aims to improve the efficacy of gene therapy by ensuring precise integration of therapeutic genes into the host genome.

Career Highlights

Goller is affiliated with the Institut für Virologie, where she conducts her research. Her work has garnered attention in the scientific community, and she is recognized for her contributions to advancing gene therapy techniques. With a total of 1 patent, her innovative approach is paving the way for new treatments in the field.

Collaborations

Throughout her career, Sabine Goller has collaborated with notable scientists, including Walter H. Günzburg and Brian Salmons. These collaborations have enriched her research and expanded the impact of her work in the field of virology and gene therapy.

Conclusion

Sabine Goller is a trailblazer in the realm of gene therapy, with her innovative patent contributing to advancements in medical science. Her dedication to research and collaboration continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…